3-(3-Cyclopropyl-1-oxopropyl)-4(R)-(1-phenylmethyl)-2-oxazolidinone, 97.0%, 5g

2-(1H-imidazol-1-yl)acetohydrazide dihydrochloride, 95.0%, 250mg

6-Bromo-3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridine, 98%, 500mg

4-(3-Bromophenyl)morpholine, 97.0%, 5g

2'-Bromo-5'-phenyl-1,1':3',1''-terphenyl>98.0%(GC)1g

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide, 98.0%, 25g

6-bromo-5-methyl-1H,2H,3H-imidazo[4,5-b]pyridine-2-thione, 97%, 1g

4,6-Dichloronicotinic acid, 98.0%, 100g

(R)-N,2-Dimethylpropane-2-sulfinamide, 95.0%, 100mg

1,4-Di(1-pyrenyl)benzene>98.0%(HPLC)200mg

2-(Trifluoromethoxy)fluorobenzene, 97.0%, 10g

(R)-3,3-Difluoro-5-(hydroxymethyl)pyrrolidin-2-one, 98%, 1g

tert-Butyl (S)-3-(2,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-(N-bis(tert-butoxycarbonyl)propanoate, 10mg